Published in Stem Cells Dev on May 02, 2014
Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov (2015) 1.18
Preconditioning stem cells for in vivo delivery. Biores Open Access (2014) 1.09
Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Reports (2014) 1.01
A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system. PLoS One (2014) 0.97
Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial. EBioMedicine (2016) 0.95
Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports (2014) 0.94
Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells (2015) 0.89
Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow. Tissue Eng Part A (2015) 0.85
Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells. Stem Cell Reports (2015) 0.81
Therapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in mice. Int J Mol Sci (2014) 0.81
A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement. Stem Cell Res Ther (2015) 0.80
Immunoevasive pericytes from human pluripotent stem cells preferentially modulate induction of allogeneic regulatory T cells. Stem Cells Transl Med (2014) 0.80
Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers. Sci Rep (2016) 0.80
Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes. Sci Rep (2015) 0.79
Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis. Sci Rep (2015) 0.78
Attenuated Innate Immunity in Embryonic Stem Cells and Its Implications in Developmental Biology and Regenerative Medicine. Stem Cells (2015) 0.78
Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells. Stem Cells Dev (2016) 0.77
HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications. Tissue Eng Part A (2015) 0.76
Adult Versus Pluripotent Stem Cell-Derived Mesenchymal Stem Cells: The Need for More Precise Nomenclature. Curr Stem Cell Rep (2016) 0.75
In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells. Stem Cell Reports (2017) 0.75
Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. Proc Natl Acad Sci U S A (2017) 0.75
An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells. Sci Rep (2017) 0.75
Hypoxia Pre-Conditioned Embryonic Mesenchymal Stem Cell Secretome Reduces IL-10 Production by Peripheral Blood Mononuclear Cells. Iran Biomed J (2016) 0.75
Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E2-EP3 signaling. Stem Cell Res Ther (2016) 0.75
Can Human Embryonic Stem Cell-Derived Stromal Cells Serve a Starting Material for Myoblasts? Stem Cells Int (2017) 0.75
Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs. Mol Ther (2017) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Mouse and human dendritic cell subtypes. Nat Rev Immunol (2002) 10.01
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood (2002) 9.40
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 7.47
A common precursor for hematopoietic and endothelial cells. Development (1998) 6.58
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood (2004) 6.02
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood (2002) 5.14
Human mesenchymal stem cells modulate B-cell functions. Blood (2005) 5.12
Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One (2008) 4.37
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood (2005) 4.10
Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev (2007) 4.02
Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development (1998) 3.94
Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol (2001) 3.84
Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med (2002) 3.81
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells (2007) 3.49
Aging of mesenchymal stem cell in vitro. BMC Cell Biol (2006) 3.32
Human embryonic stem cell lines derived from single blastomeres. Nature (2006) 3.12
Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med (2005) 3.04
Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica (2006) 2.75
Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol (2007) 2.65
Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia (2003) 2.39
Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One (2010) 2.38
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest (2013) 2.34
Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev (2004) 2.30
Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol (2010) 2.27
Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) (2008) 2.23
Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells (2006) 2.11
Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells (2012) 2.09
Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods (2007) 2.06
The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy (2013) 1.99
Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells (2006) 1.92
Mesenchymal stem cell preparations--comparing apples and oranges. Stem Cell Rev (2007) 1.88
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood (2005) 1.86
"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther (2007) 1.85
Murine models of systemic lupus erythematosus. J Biomed Biotechnol (2011) 1.84
Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol (2008) 1.80
Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther (2011) 1.70
Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics (2007) 1.51
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48
Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol (2007) 1.46
Rodent models of experimental autoimmune uveitis. Methods Mol Med (2004) 1.43
Mesenchymal stromal cell 'licensing': a multistep process. Leukemia (2011) 1.42
Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med (2012) 1.41
Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol (2003) 1.32
Derivation of human embryonic stem cells from single blastomeres. Nat Protoc (2007) 1.32
Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30
Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells (2011) 1.27
Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J Cell Physiol (2010) 1.26
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood (2008) 1.26
The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs (2008) 1.24
The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood (2011) 1.24
Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica (2008) 1.23
Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res (2010) 1.19
Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine. Stem Cell Res (2009) 1.16
The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol (2011) 1.16
Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med (2012) 1.14
Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol (2007) 1.14
Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A (2011) 1.13
Successes and failures of stem cell transplantation in autoimmune diseases. Hematology Am Soc Hematol Educ Program (2011) 1.08
Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells (2009) 1.07
Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant (2010) 1.07
CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseases. Trends Immunol (2007) 1.07
One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res (2012) 1.06
Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One (2012) 1.05
Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum (2012) 1.05
Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2012) 1.02
Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma. J Immunother (2009) 1.01
Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Stem Cells Dev (2012) 1.01
Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. Tissue Eng Part C Methods (2012) 1.01
Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion. Exp Hematol (2012) 1.00
Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin Exp Immunol (2010) 1.00
Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells. Biochem Biophys Res Commun (2012) 0.94
Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration. PLoS One (2013) 0.94
Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regen Med (2009) 0.93
Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Invest Ophthalmol Vis Sci (2011) 0.92
Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS One (2013) 0.90
Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regen Med (2008) 0.88
The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clin Exp Immunol (2013) 0.88
Dendritic cells in vivo and in vitro. Cell Mol Immunol (2005) 0.88
The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells. J Immunol (2011) 0.84
An extended transcriptional network for pluripotency of embryonic stem cells. Cell (2008) 14.64
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell (2009) 10.52
A protein interaction network for pluripotency of embryonic stem cells. Nature (2006) 9.63
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell (2010) 6.00
Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (2010) 3.48
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum (2007) 3.32
Human embryonic stem cell lines derived from single blastomeres. Nature (2006) 3.12
Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell (2008) 3.11
Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01
Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (2009) 2.56
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2009) 2.31
Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells (2008) 2.29
Human embryonic stem cells derived without feeder cells. Lancet (2005) 2.24
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23
Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells (2006) 2.23
Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods (2007) 2.06
Platelet bioreactor-on-a-chip. Blood (2014) 1.87
Birdshot chorioretinopathy. Surv Ophthalmol (2005) 1.87
Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature (2005) 1.86
Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol (2012) 1.70
Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum (2007) 1.50
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48
Relationship of AcrySof acrylic and PhacoFlex silicone intraocular lenses to visual acuity and posterior capsule opacification. J Cataract Refract Surg (2002) 1.46
Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40
Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov (2008) 1.38
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2012) 1.33
Derivation of human embryonic stem cells from single blastomeres. Nat Protoc (2007) 1.32
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A (2011) 1.30
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol (2003) 1.28
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum (2009) 1.23
Improving the detection limit of anion-selective electrodes: an iodide-selective membrane with a nanomolar detection limit. Anal Chem (2003) 1.19
Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer (2009) 1.19
Functional nanoprobes for ultrasensitive detection of biomolecules. Chem Soc Rev (2010) 1.17
Modulation of dopamine release by striatal 5-HT2C receptors. Synapse (2005) 1.16
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13
Fiber-optic microsensor array based on fluorescent bulk optode microspheres for the trace analysis of silver ions. Anal Chem (2005) 1.12
Electrochemical sensors. Anal Chem (2006) 1.12
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum (2009) 1.11
Harnessing endogenous growth factor activity modulates stem cell behavior. Integr Biol (Camb) (2011) 1.09
Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice. Biochem Pharmacol (2009) 1.05
Extracellular signal-regulated kinase activation during renal ischemia/reperfusion mediates focal adhesion dissolution and renal injury. Am J Pathol (2007) 1.04
Association of IRF5 polymorphisms with activation of the interferon alpha pathway. Ann Rheum Dis (2009) 1.02
Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience. J Gastroenterol Hepatol (2007) 1.02
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One (2010) 1.02
Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Invest Ophthalmol Vis Sci (2011) 1.01
Association of smoking, alcohol drinking and dietary factors with esophageal cancer in high- and low-risk areas of Jiangsu Province, China. World J Gastroenterol (2006) 1.00
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum (2005) 1.00
Cellular and molecular mechanisms of regulation of autoantibody production in lupus. Ann N Y Acad Sci (2005) 0.99
Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev (2007) 0.99
Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol (2006) 0.99
Longitudinal cohort study of patients with birdshot chorioretinopathy. III. Macular imaging at baseline. Am J Ophthalmol (2007) 0.96
Blood pressure changes and chemical constituents of particulate air pollution: results from the healthy volunteer natural relocation (HVNR) study. Environ Health Perspect (2012) 0.96
Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev (2005) 0.96
Standardized visual field assessment for patients with birdshot chorioretinopathy. Ocul Immunol Inflamm (2006) 0.93
Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regen Med (2009) 0.93
HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm (2011) 0.93
GeneChip analysis of human embryonic stem cell differentiation into hemangioblasts: an in silico dissection of mixed phenotypes. Genome Biol (2007) 0.92
Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cells. Clin Exp Metastasis (2009) 0.92
Application of siRNA in targeting protein expression in kidney disease. Adv Drug Deliv Rev (2010) 0.92
Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. J Rheumatol (2006) 0.92
Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure. J Am Soc Nephrol (2011) 0.91
Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease. J Immunol (2010) 0.91
Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg (2011) 0.91
Optical chloride sensor based on [9]mercuracarborand-3 with massively expanded measuring range. Talanta (2004) 0.89
Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway. Stem Cells (2013) 0.89
Mechanistic insights into the development of optical chloride sensors based on the [9]mercuracarborand-3 ionophore. Anal Chem (2003) 0.89
A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2007) 0.89
Paper-based plasticizer-free sodium ion-selective sensor with camera phone as a detector. Chem Commun (Camb) (2015) 0.88
Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Mol Cancer (2014) 0.88
Stomping out barriers for hRBC mouse models. Blood (2011) 0.88
Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regen Med (2008) 0.88
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol (2014) 0.87
MicroRNA-125b inhibits lens epithelial cell apoptosis by targeting p53 in age-related cataract. Biochim Biophys Acta (2014) 0.87
Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. Atherosclerosis (2009) 0.87
P16 and p53 play distinct roles in different subtypes of breast cancer. PLoS One (2013) 0.86
Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy. Neurotherapeutics (2009) 0.86
Polymeric optodes based on upconverting nanorods for fluorescent measurements of pH and metal ions in blood samples. Anal Chem (2012) 0.86
alpha-Thalassemia-like globin gene expression by primitive erythrocytes derived from human embryonic stem cells. Hemoglobin (2010) 0.86
Characterization of canine embryonic stem cell lines derived from different niche microenvironments. Stem Cells Dev (2009) 0.86
Embryonic stem cells as a treatment for macular degeneration. Expert Opin Biol Ther (2013) 0.85
Longitudinal cohort study of patients with birdshot chorioretinopathy. IV. Visual field results at baseline. Am J Ophthalmol (2007) 0.85
Beta(2)-adrenergic receptor haplotype/polymorphisms and asthma susceptibility and clinical phenotype in a Chinese Han population. Allergy Asthma Proc (2010) 0.85
Defective DNA double-strand break repair in pediatric systemic lupus erythematosus. Arthritis Rheum (2012) 0.85
Chemical constituents of fine particulate air pollution and pulmonary function in healthy adults: the Healthy Volunteer Natural Relocation study. J Hazard Mater (2013) 0.85
One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation. Bioorg Med Chem (2006) 0.85
Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice. J Immunol (2009) 0.85
Chemical constituents of ambient particulate air pollution and biomarkers of inflammation, coagulation and homocysteine in healthy adults: a prospective panel study. Part Fibre Toxicol (2012) 0.84
Isoflavone consumption and risk of breast cancer: a dose-response meta-analysis of observational studies. Asia Pac J Clin Nutr (2013) 0.84
Association of dietary pattern and body weight with blood pressure in Jiangsu Province, China. BMC Public Health (2014) 0.83
Directed differentiation of red blood cells from human embryonic stem cells. Methods Mol Biol (2010) 0.83
Astrocyte elevated gene-1 activates MMP9 to increase invasiveness of colorectal cancer. Tumour Biol (2014) 0.83
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Mol Cancer Ther (2014) 0.83
Stem cell breakthrough: don't forget ethics. Science (2007) 0.82
China belting up or down? Seat belt wearing trends in Nanjing and Zhoushan. Accid Anal Prev (2008) 0.82
Activation of nuclear factor erythroid 2-related factor 2 and PPARγ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. Br J Nutr (2012) 0.82
Association of cardiopulmonary health effects with source-appointed ambient fine particulate in Beijing, China: a combined analysis from the Healthy Volunteer Natural Relocation (HVNR) study. Environ Sci Technol (2014) 0.82
Anthocyanin extract from black rice significantly ameliorates platelet hyperactivity and hypertriglyceridemia in dyslipidemic rats induced by high fat diets. J Agric Food Chem (2011) 0.82